Merck and Eisai's experimental combination treatment helped extend the time certain patients with advanced kidney cell cancer lived without their disease progressing, according to interim data from a ...

FILE PHOTO: A vial and syringe are seen in front of Merck logo in this illustration taken March 26, 2025. REUTERS/Dado Ruvic/Illustration/File Photo (Reuters) -Merck and Eisai's experimental ...

Zai Lab Limited's narrowing losses and promising R&D pipeline make it an attractive entry point for investors. Learn more ...

Rezoning is often a key issue in property redevelopment, but perhaps none more so than Bolton Estates, which has undergone a ...

Skye Bioscience, Inc. ((SKYE)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter ...

Venetoclax improved PFS but not OS in relapsed/refractory multiple myeloma, with significant benefits in t(11;14) and/or BCL2high subgroups. The overall response rate was higher with venetoclax, and ...

New features, battery fixes, and accessibility updates. Learn what works and what still needs improvement in this update.

T. Rowe Price Dividend Growth ETF offers active management focused on dividend and earnings growth, not high yield. Read why ...

Oklo has been one of the hottest stocks at the intersection of artificial intelligence (AI) and nuclear energy.

Alcohol consumption is injurious to health. Cocktail is a mixed alcoholic drink, made by combining one or more types of ...

Moby had all but thrown in the towel, but the surprising success of his eclectic 1999 masterpiece forever changed his ...